| Greater trochanteric pain syndrome: predicting who will respond to a local glucocorticoid injection | Scandinavian Journal of Rheumatology |  | | 2021 | 263 | 0 |
|
| Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab | RMD open |  | | 2021 | 267 | 129 |
|
| Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland | RMD Open | | | 2020 | 224 | 129 |
|
| Discordances between clinical and ultrasound measurements of disease activity among RA patients followed in real life | Joint, Bone, Spine | | | 2020 | 365 | 0 |
|
| Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years | Rheumatology | | | 2019 | 318 | 221 |
|
| Glucocorticoid injections for greater trochanteric pain syndrome: a randomised double-blind placebo-controlled (GLUTEAL) trial | Clinical Rheumatology | | | 2019 | 320 | 0 |
|
| Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis | RMD Open | | | 2019 | 343 | 138 |
|
| Can Ultrasound Be Used to Predict Loss of Remission in Patients with RA in a Real-life Setting? A Multicenter Cohort Study | Journal of Rheumatology | | | 2018 | 454 | 0 |
|
| The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis | Clinical Rheumatology | | | 2017 | 635 | 3 |
|
| Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists | Joint bone spine | | | 2010 | 722 | 0 |
|
| B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents | Arthritis and rheumatism | | | 2007 | 183 | 1 |
|
